首页> 外文期刊>Chemistry Select >Triosephosphate Isomerase Inhibitors as Potential Drugs against Clostridium perfringens
【24h】

Triosephosphate Isomerase Inhibitors as Potential Drugs against Clostridium perfringens

机译:三尿磷酸异构酶抑制剂作为针对灌注梭状芽胞杆菌的潜在药物

获取原文
获取原文并翻译 | 示例
           

摘要

Clostridium perfringes is a gram-positive anaerobic bacillus responsible for various infections in humans and the main cause of diseases such as gas gangrene, bacterial-associated diarrhea and food poisoning. Resistances to conventional medications have been identified in different strains of C. perfringens. Therefore, the development of new drugs against this bacterium is necessary. Here we use structural information of C. perfringens (CpTIM) and human (HsTIM) triosephosphate isomerase to look for specific CpTIM inhibitors by means of high-performance virtual detection. We selected nine com- pounds (C1 - C9) with high probability of CpTIM binding and low potential to bind to HsTIM, these compounds without report of specific use as an antibiotic. We determined that C2 and C4 decrease the activity of CpTIM by approximately 60%, while HsTIM is not primarily affected (10%). Therefore, C2 and C4 or their chemical derivatives should be further investigated as potential drugs against Clostridium perfringens.
机译:梭状芽胞杆菌渗透是一种革兰氏阳性厌氧菌杆菌,负责人类的各种感染以及诸如气候坏疽,细菌相关腹泻和食物中毒之类的疾病的主要原因。在不同菌株的灌注蛋白酶菌株中已经鉴定出对常规药物的耐药性。因此,必须开发针对该细菌的新药。在这里,我们使用灌注梭菌(CPTIM)和人(Hstim)三氧磷酸异构酶的结构信息来通过高性能虚拟检测来寻找特定的CPTIM抑制剂。我们选择了九个分数(C1 -C9),具有CPTIM结合的可能性很高,与Hstim结合的潜力很低,这些化合物没有特定用作抗生素的特定用途。我们确定C2和C4将CPTIM的活性降低了约60%,而HSTIM不主要受到影响(10%)。因此,应进一步研究C2和C4或其化学衍生物作为针对灌注梭状芽胞杆菌的潜在药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号